Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B

Published:2011-10 Issue:4 Volume:51 Page:262-267
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Cao Ju,Zhang Liping,Huang Shifeng,Chen Pu,Zou Lin,Chen Hui,Xiang Yu,Lai Xiaofei,Ren Guosheng

Funder

National Natural Science Foundation grants of China

Chongqing Natural Science Foundation grants

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference45 articles.

1. The maze of treatments for hepatitis B;Lok;N Engl J Med,2005

2. Managing HBV in patients with impaired immunity;Wursthorn;Gut,2010

3. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury;Rehermann;J Exp Med,2000

4. How chronic viral infections impact on antigen-specific T-cell responses;Frebel;Eur J Immunol,2010

5. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B;Zhang;Hepatology,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence;Immunity & Ageing;2024-01-20

2. Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study;International Journal of Molecular Sciences;2023-12-29

3. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation;Frontiers in Immunology;2023-03-28

4. Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity;Frontiers in Physiology;2021-03-10

5. Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection;International Immunopharmacology;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3